Laboratory Audits Sample Clauses

Laboratory Audits. Each laboratory working on the Xxxxx project is required to participate in an annual on-site laboratory audit carried out by the EPA through the QATS contract. These audits are performed by EPA personnel (and their contractors), that are external to and independent of, the Xxxxx laboratory team members. These audits ensure that each analytical laboratory meets the basic capability and quality standards associated with analytical methods for asbestos used at the Xxxxx site. They also provide information on the availability of sufficient laboratory capacity to meet potential testing needs associated with the Site. Audits consist of several days of technical and evidentiary review of each laboratory. The technical portion of the audit involves an evaluation of laboratory practices and procedures associated with the preparation and analysis of samples for the identification of asbestos. The 9 The most recent version of the laboratory ROM form is available in the Xxxxx Lab eRoom. evidentiary portion of the audit involves an evaluation of data packages, record keeping, SOPs, and the laboratory QA Management Plan. A checklist of method-specific requirements for the commonly used methods for asbestos analysis is prepared by the auditor prior to the audit, and used during the on-site laboratory evaluation. Evaluation of the capability for a laboratory to analyze a sample by a specific method is made by observing analysts performing actual sample analyses and interviewing each analyst responsible for the analyses. Observations and responses to questions concerning items on each method-specific checklist are noted. The determination as to whether the laboratory has the capability to analyze a sample by a specific method depends on how well the analysts follow the protocols detailed in the formal method, how well the analysts follow the laboratory- specific method SOPs, and how the analysts respond to method-specific questions. Evaluation of the laboratory to be sufficient in the evidentiary aspect of the audit is made by reviewing laboratory documentation and interviewing laboratory personnel responsible for maintaining laboratory documentation. This includes personnel responsible for sample check- in, data review, QA procedures, document control, and record archiving. Certain analysts responsible for method quality control, instrument calibration, and document control are also interviewed in this aspect of the audit. Determination as to the capability to be sufficie...
AutoNDA by SimpleDocs
Laboratory Audits. Laboratory audits include both onsite technical and offsite systems evaluations. Laboratory audits may be requested by facilities or by RWQCB or USEPA . The audit requirements shall be documented in the site -specific work plan. will be covered in a technical systems audit of the laboratory include :  Certification and training records .  Calibration procedures an d documentation .  Treatment and handling of standards .  Completeness of data forms, notebooks, and other reporting requirements .  Data review and verification procedures .  Data storage, filing, and recordkeeping procedures .  Sample custody procedures .  Quality c ontrol procedures, tolerances, and documentation .  Operating conditions of facilities and equipment .  Documentation of staff training and instrument maintenance activities .  Systems and operations overview . A written audit report will then be sent to the labo ratory within a specified time. A copy of the audit report will be sent to the project -specific Project Manager . A copy will be retained in the project files. The need for follow -up action will be determined based on the laboratory ’s responses. If an audit identifies an unacceptable condition or unacceptable data, the auditor will be responsible for developing and initiating corrective action. The Project Manager will be notified if the non -conformance impacts the project and requires resources not normally available to the project team. In such cases, the Project Manager will decide whether resources to pursue corrective action will be made available. Disposition may include:  Reanalysis of samples if holding time has not expired .  Resampling and analysis .  Amending analytical procedures .  Acceptance of suspect data acknowledging the limits on usability .

Related to Laboratory Audits

  • Laboratory a. Drug tests shall be conducted by laboratories licensed and approved by SAMSHA which comply with the American Occupational Medical Association (AOMA) ethical standards. Upon advance notice, the parties retain the right to inspect the laboratory to determine conformity with the standards described in this policy. The laboratory will only test for drugs identified in this policy. The City shall bear the cost of all required testing unless otherwise specified herein. b. Tests for all controlled substances, except alcohol, shall be by oral fluid testing and shall consist of two procedures, a screen test and, if that is positive, a confirmation test. c. To be considered positive for reporting by the laboratory to the City, both samples must be tested separately in separate batches and must also show positive results on the confirmatory test. d. In the event of a positive test, the testing laboratory will perform an automatic confirmation test on the original specimen at no cost to the Covered Employee. In addition, the testing laboratory shall preserve a sufficient specimen to permit an independent re-testing at the Covered Employee’s request and expense. The same, or any other, approved laboratory may conduct re-tests. The laboratory shall endeavor to notify the designated MRO of positive drug, alcohol, or adulterant tests results within five (5) working days after receipt of the specimen.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • City Audits The CITY may perform an independent audit. Such audits may cover programmatic as well as fiscal matters. GRANTEE will be afforded an opportunity to respond to any audit findings, and have the responses included in the final audit report. Costs of such audits will be borne by the CITY.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

  • Field The term “

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Audits No more than once a year, or following unauthorized access, upon receipt of a written request from the LEA with at least ten (10) business days’ notice and upon the execution of an appropriate confidentiality agreement, the Provider will allow the LEA to audit the security and privacy measures that are in place to ensure protection of Student Data or any portion thereof as it pertains to the delivery of services to the LEA . The Provider will cooperate reasonably with the LEA and any local, state, or federal agency with oversight authority or jurisdiction in connection with any audit or investigation of the Provider and/or delivery of Services to students and/or LEA, and shall provide reasonable access to the Provider’s facilities, staff, agents and XXX’s Student Data and all records pertaining to the Provider, LEA and delivery of Services to the LEA. Failure to reasonably cooperate shall be deemed a material breach of the DPA.

  • Geotechnical Investigation Perform in accordance with the City Design Manual and other City requirements as designated in writing by the Director.

  • Contract Audits Eligible Purchaser represents and warrants that it shall cooperate with Enterprise Services, the Office of the State Auditor, federal officials, and/or any third party authorized by law or contract, in any audit conducted by such party pertaining to any Contracts that Eligible Purchaser has made purchases from pursuant to this Agreement, including providing records related to any purchases from such Contracts.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!